Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Saved in:
| Title: | Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial. |
|---|---|
| Authors: | Häring, Hans-Ulrich1 hans-ulrich.haering@med.uni-tuebingen.de, Merker, Ludwig2, Seewaldt-Becker, Elke3, Weimer, Marc3, Meinicke, Thomas3, Broedl, Uli C.4, Woerle, Hans J.4 |
| Source: | Diabetes Care. Jun2014, Vol. 37 Issue 6, p1650-1659. 10p. 3 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 01495992 |
|---|---|
| DOI: | 10.2337/dc13-2105 |
